Jefferson Neurocritical Care
@TJUHNeuroCrit
Built on three pillars: quality critical care, strong academics, and robust research. All with a Philly flare!
Yi Ong et al: Electroconvulsive Therapy in Refractory and Super-Refractory Status Epilepticus in Adults: A Scoping Review Link: link.springer.com/article/10.100… @neurocritical #neurocritcare
Looking for a great neurocritical care fellowship?
Thoughtful presentation by Dr. Monisha Kumar on the impact of health care disparities. @TjuhNeurology @TJUHNeurosurg
Thank you to Dr. Emily Gilmore for giving a fantastic talk on Neuromonitoring at the NCC Symposium. @TjuhNeurology @TJUHNeurosurg
Dr. Ume presenting on Status Epilepticus and NORSE. #NCCSymposium, #JeffersonNeurocritCare
Looking forward to this discussion on Neurosurgical Robotics! @TJUHNeurosurg @TJUHospital @JNSPG_EIC @TheJNS
#JNSJournalClub Dont miss this discussion on #robotics in the #neurosurgical OR! From robotic carotid artery stenting to a new soft robot for #skullbase approaches. Register today! @TJUHNeurosurg @NeurosurgUCSF Neurosurgical Atlas attendee link:us02web.zoom.us/webinar/regist…
Kartal et al: How to Define and Meet Blood Pressure Targets After Traumatic Brain Injury: A Narrative Review Link: ow.ly/CTrv50TtSUe @neurocritical #neurocritcare
This will require in depth reading and discussion later… One of the few studies on transfusion thresholds where liberal seems better. All randomized patients were anemic.
A liberal transfusion strategy compared with a restrictive strategy resulted in a lower rate of unfavorable neurological outcome among patients with acute brain injury. ja.ma/3ZXqw2S #LIVES2024
1/ The @UFNeuroICU Research Team proudly presents their latest manuscript! Efficacy of COXIBs for headache after ABI— A systematic review: bit.ly/3XlLchX A 🧵with key points from our paper: #NeuroTwitter
Status epilepticus drugs pocket card from CHEST. #FOAMed #FOAMcc #ICU
It’s that time of the year! Celebrating the graduation of our amazing stroke fellows, Mitchell & Courtney! @NeuroatJeff @JeffersonGME
#MondayTip 🩸ICH Dawn of a New Era 🌎"ICH is a devastating disease, causing high rates of death, disability, and suffering across the world" 🎉2023 was a good year in ICH field: INTERACT3 ENRICH ANNEXa-1 💪and 2024 is not disappointing: INTERACT4 SWITCH 🔗journals.sagepub.com/doi/10.1177/17…
How should #neurocriticalcare divisions build onboarding programs for new advanced practice providers? And what activities should NCC #APPs be expected to perform by the end of onboarding? We addressed these ❓❓ in our manuscript in @critcaremed! A 🧵 journals.lww.com/ccmjournal/abs…
Our latest in @JAMANeuro. A systematic review of 66 studies (1637 patients) for RSE with CI ASMs. Lots of interesting findings including epilepsy related RSE with lower mortality compared to other etiologies. @TJUHNeuroCrit @AndresFdezMD @DrHirschEEG tinyurl.com/kvh7ark5
Congratulations to Dr. Michael Sperling, the proud recipient of the American Clinical Neurophysiology Society, Herbert H. Jasper Award, recognizing a lifetime of outstanding contributions to the field of clinical neurophysiology including research, teaching, and mentoring.
The Jefferson Telestroke Program being presented by @omarshahmd @TJUHNeurosurg @NeuroatJeff @TjuhNeurology
You can now read our latest paper @JAMANetworkOpen The evidence from RCTs suggests that intensive post-EVT BP reduction does not yield benefits and may carry risks. Read more here: bit.ly/49K1RjL @MohamedElfilMD @HassKobeissi @Alzhraa_S_Abbas @MayoNeurvascLab
Fellowship Training Directors: #ACGME's Revised NCC Program Requirements are releasing this week and expect to address the lack of availability of qualified RFP neurosurgeons to serve as core faculty in NCC fellowship programs. Review, comment and share: ow.ly/3f6h50QBv8J
New data from @ELAN_Trial presented by @StrokeBern @FishingNeurons and @mbgoeldlin suggest that benefit of early start of DOAC after stroke is equal for all stroke sizes, probably even biggest in large sized strokes. Investigators did a great job estimimating stroke size 👏👏